Miranda Patterson
Impact in
- Oncology top 10%
- PARP inhibition in cancer therapy
- Lung Cancer Research Studies
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
Papers in
- Oncology 9
- PARP inhibition in cancer therapy 5
- Peptidase Inhibition and Analysis 2
-
- DNA Repair Mechanisms 4
- Cell death mechanisms and regulation 2
- Co-authors
- Janet Quinn (5 shared papers)Deborah A. Smith (4 shared papers)Alessandra da Silva Dantas (4 shared papers)Nicola J. Curtin (6 shared papers)Ashleigh Herriott (4 shared papers)Zev A. Wainberg (1 shared paper)John A. Glaspy (1 shared paper)Lauren A. Byers (1 shared paper)
- Journals
- British Journal of Cancer (2 papers)mBio (2 papers)Oncotarget (2 papers)Molecular Biology of the Cell (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Miranda Patterson
12 papers receiving 807 citations
Peers
Comparison fields: 5 of 77
- Oncology 427
- Infectious Diseases 233
- Molecular Biology 426
- Epidemiology 174
- Reproductive Medicine 40
Countries citing papers authored by Miranda Patterson
This map shows the geographic impact of Miranda Patterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miranda Patterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miranda Patterson more than expected).
Fields of papers citing papers by Miranda Patterson
This network shows the impact of papers produced by Miranda Patterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miranda Patterson. The network helps show where Miranda Patterson may publish in the future.
Co-authors
The 25 scholars most cited alongside Miranda Patterson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 314 | |
| 2 | 2010 | 99 | |
| 3 | 2007 | 92 | |
| 4 | 2014 | 73 | |
| 5 | 2013 | 63 | |
| 6 | 2015 | 47 | |
| 7 | 2014 | 33 | |
| 8 | 2016 | 32 | |
| 9 | 2015 | 29 | |
| 10 | 2014 | 19 | |
| 11 | 1966 | 14 | |
| 12 | 1967 | 2 | |
| 13 | 2013 | 1 | |
| 14 | 2017 | 0 |
About Miranda Patterson
Miranda Patterson is a scholar working on Oncology, Molecular Biology, Infectious Diseases, Epidemiology and Genetics, having authored 14 papers that have together received 818 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (5 papers), PARP inhibition in cancer therapy (5 papers), DNA Repair Mechanisms (4 papers), Fungal Infections and Studies (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), Cell death mechanisms and regulation (2 papers), Peptidase Inhibition and Analysis (2 papers) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Oncology (427 citations), Infectious Diseases (233 citations), Molecular Biology (426 citations), Epidemiology (174 citations) and Reproductive Medicine (40 citations). Miranda Patterson has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Janet Quinn, Deborah A. Smith, Alessandra da Silva Dantas, Nicola J. Curtin, Ashleigh Herriott, Zev A. Wainberg, John A. Glaspy, Lauren A. Byers, Donna M. MacCallum and David C. Smith. Their work appears in journals such as British Journal of Cancer, mBio, Oncotarget, Molecular Biology of the Cell and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.